Published • loading... • Updated
Israel's Benjamin Netanyahu treated for early-stage prostate cancer
Doctors found a tiny malignant lesion during routine follow-up, and Netanyahu said targeted radiation removed it without interrupting his duties.
- Israeli Prime Minister Benjamin Netanyahu revealed Friday he successfully underwent treatment for an early-stage malignant prostate tumor, declaring he is now in "excellent physical condition."
- Following surgery in 2024 for an enlarged benign prostate, doctors discovered a 0.9-centimeter mass during routine monitoring at Hadassah Medical Center in Jerusalem.
- Netanyahu delayed the report's release by two months to prevent Iran from spreading "even more false propaganda against Israel" during the ongoing conflict.
- Targeted radiation therapy "removed the problem and left no trace of it," allowing the Prime Minister to continue working throughout the procedure, according to medical staff.
- Netanyahu is scheduled to visit the White House in the coming weeks as the administration seeks to broker a lasting peace deal with Iran.
Insights by Ground AI
Podcasts & Opinions
292 Articles
292 Articles
der Standard ATReposted by 
der Standard DE
der Standard DENetanyahu was operated on at the end of 2024 for benign prostate enlargement. In a follow-up examination, the tumor was discovered at a very early stage.
·Vienna, Austria
Read Full Article
Israeli Prime Minister Benjamin Netanyahu has revealed that he was diagnosed with prostate cancer and has received treatment. Rumors of his ill health have been circulating since March, shortly after the outbreak of the Middle East war. On the 24th (local time), Prime Minister Netanyahu posted on X (formerly Twitter), “Today my
Israeli Prime Minister Benjamin Netanyahu acknowledges having undergone treatment to overcome a cancer problem in his prostate
Coverage Details
Total News Sources292
Leaning Left44Leaning Right60Center60Last UpdatedBias Distribution37% Center, 36% Right
Bias Distribution
- 37% of the sources are Center, 36% of the sources lean Right
37% Center
L 27%
C 37%
R 36%
Factuality
To view factuality data please Upgrade to Premium
